Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registration Study on Drug Treatment for Comorbid Depression in Patients With Epilepsy in East China

NCT03247764 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT03247764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03247764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registration Study on Drug Treatment for Comorbid Depression in Patients With Epilepsy in East China
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2018
Completion date
January 31, 2022
Enrollment
320 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

depression, epilepsy